News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
730,837 Results
Type
Article (44752)
Company Profile (316)
Press Release (685759)
Multimedia
Podcasts (85)
Webinars (17)
Section
Business (206328)
Career Advice (2043)
Deals (35704)
Drug Delivery (113)
Drug Development (82070)
Employer Resources (174)
FDA (16526)
Job Trends (15061)
News (349047)
Policy (33011)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2654)
Accelerated approval (34)
Adcomms (27)
Allergies (143)
Alliances (50131)
ALS (173)
Alzheimer's disease (1675)
Antibody-drug conjugate (ADC) (313)
Approvals (16775)
Artificial intelligence (521)
Autoimmune disease (153)
Automation (39)
Bankruptcy (365)
Best Places to Work (11729)
BIOSECURE Act (21)
Biosimilars (189)
Biotechnology (214)
Bladder cancer (158)
Brain cancer (59)
Breast cancer (641)
Cancer (4835)
Cardiovascular disease (401)
Career advice (1724)
Career pathing (36)
CAR-T (286)
CDC (44)
Celiac Disease (2)
Cell therapy (760)
Cervical cancer (36)
Clinical research (70012)
Collaboration (1726)
Company closure (4)
Compensation (1167)
Complete response letters (58)
COVID-19 (2747)
CRISPR (93)
C-suite (857)
Cystic fibrosis (145)
Data (6251)
Decentralized trials (2)
Denatured (26)
Depression (132)
Diabetes (501)
Diagnostics (6764)
Digital health (49)
Diversity (12)
Diversity, equity & inclusion (46)
Drug discovery (258)
Drug pricing (186)
Drug shortages (28)
Duchenne muscular dystrophy (233)
Earnings (90562)
Editorial (57)
Employer branding (21)
Employer resources (153)
Events (118487)
Executive appointments (978)
FDA (19647)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (24)
Funding (1481)
Gene editing (208)
Generative AI (44)
Gene therapy (625)
GLP-1 (975)
Government (4698)
Grass and pollen (7)
Guidances (383)
Healthcare (19011)
HIV (60)
Huntington's disease (46)
IgA nephropathy (83)
Immunology and inflammation (251)
Immuno-oncology (57)
Indications (110)
Infectious disease (3017)
Inflammatory bowel disease (189)
Inflation Reduction Act (14)
Influenza (116)
Intellectual property (248)
Interviews (321)
IPO (16713)
IRA (50)
Job creations (3682)
Job search strategy (1442)
JPM (59)
Kidney cancer (16)
Labor market (85)
Layoffs (558)
Leadership (31)
Legal (8019)
Liver cancer (93)
Longevity (14)
Lung cancer (651)
Lymphoma (377)
Machine learning (42)
Management (59)
Manufacturing (793)
MASH (164)
Medical device (13786)
Medtech (13839)
Mergers & acquisitions (20059)
Metabolic disorders (1274)
Multiple sclerosis (160)
NASH (16)
Neurodegenerative disease (317)
Neuropsychiatric disorders (89)
Neuroscience (2913)
Neurotech (1)
NextGen: Class of 2026 (6606)
Non-profit (4596)
Now hiring (67)
Obesity (599)
Opinion (265)
Ovarian cancer (166)
Pain (200)
Pancreatic cancer (228)
Parkinson's disease (280)
Partnered (33)
Patents (497)
Patient recruitment (491)
Peanut (56)
People (59405)
Pharmaceutical (65)
Pharmacy benefit managers (29)
Phase 1 (21894)
Phase 2 (30795)
Phase 3 (22934)
Pipeline (5285)
Policy (284)
Postmarket research (2589)
Preclinical (9333)
Press Release (67)
Prostate cancer (238)
Psychedelics (49)
Radiopharmaceuticals (281)
Rare diseases (876)
Real estate (6016)
Recruiting (70)
Regulatory (24699)
Reports (52)
Research institute (2493)
Resumes & cover letters (355)
Rett syndrome (27)
RNA editing (17)
RSV (77)
Schizophrenia (149)
Series A (243)
Series B (192)
Service/supplier (13)
Sickle cell disease (101)
Special edition (22)
Spinal muscular atrophy (168)
Sponsored (41)
Startups (3683)
State (2)
Stomach cancer (17)
Supply chain (104)
Tariffs (85)
The Weekly (57)
Vaccines (1018)
Venture capital (90)
Weight loss (384)
Women's health (91)
Worklife (18)
Date
Last 7 days (611)
Last 30 days (2026)
Last 365 days (29980)
2026 (3451)
2025 (30391)
2024 (35510)
2023 (40356)
2022 (51562)
2021 (56070)
2020 (54431)
2019 (46928)
2018 (35347)
2017 (32489)
2016 (31978)
2015 (37996)
2014 (31700)
2013 (26900)
2012 (29092)
2011 (29755)
2010 (27811)
Location
Africa (764)
Alabama (83)
Alaska (7)
Arizona (310)
Arkansas (13)
Asia (39778)
Australia (6536)
California (11352)
Canada (3289)
China (1102)
Colorado (477)
Connecticut (483)
Delaware (336)
Europe (86257)
Florida (1690)
Georgia (355)
Hawaii (3)
Idaho (62)
Illinois (860)
India (65)
Indiana (522)
Iowa (23)
Japan (431)
Kansas (126)
Kentucky (39)
Louisiana (26)
Maine (72)
Maryland (1390)
Massachusetts (8158)
Michigan (324)
Minnesota (629)
Mississippi (5)
Missouri (128)
Montana (32)
Nebraska (28)
Nevada (122)
New Hampshire (79)
New Jersey (3004)
New Mexico (29)
New York (2988)
North Carolina (1466)
North Dakota (9)
Northern California (5545)
Ohio (335)
Oklahoma (21)
Oregon (41)
Pennsylvania (2290)
Puerto Rico (24)
Rhode Island (48)
South America (1132)
South Carolina (66)
South Dakota (1)
Southern California (4408)
Tennessee (174)
Texas (1744)
United States (40252)
Utah (334)
Vermont (1)
Virginia (260)
Washington D.C. (82)
Washington State (968)
West Virginia (4)
Wisconsin (109)
Wyoming (2)
730,837 Results for "seattle genetics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
AGC Biologics Seattle Site Now Certified to Manufacture Biologics for Largest Pharmaceutical Market in South America
February 4, 2026
·
4 min read
Press Releases
Opus Genetics Announces $25 Million Private Placement
February 13, 2026
·
5 min read
Press Releases
Seattle Children’s appoints Dr. Christopher Longhurst as chief executive officer
October 9, 2025
·
4 min read
Press Releases
Targeted Genomics Launches Celiac Genetic Testing Services for Texas Physicians
February 2, 2026
·
2 min read
Press Releases
Baylor Genetics to Highlight Genetic Testing Use Cases and Advancements in Rare Disease at The National Society of Genetic Counselors 44th Annual Conference
November 5, 2025
·
2 min read
Press Releases
Opus Genetics to Participate in Upcoming Medical and Industry Conferences in February 2026
February 2, 2026
·
2 min read
Press Releases
Myriad Genetics to Highlight Genetic Testing Advancements at 2025 National Society of Genetic Counselors Annual Conference
November 7, 2025
·
3 min read
Biotech Bay
Avirmax Biopharma Inc. to Present at the 2024 ARVO Annual Meeting in Seattle
Avirmax Biopharma Inc., will make three scientific presentations at the 2024 Association for Research in Vision and Ophthalmology (ARVO) annual meeting in Seattle between May 5th and 9th, 2024.
April 1, 2024
·
2 min read
Press Releases
Genethon Advances Groundbreaking Gene Therapies for Patients with Rare Genetic Diseases
January 27, 2026
·
1 min read
Press Releases
Opus Genetics Highlights 2025 Progress and Upcoming 2026 Catalysts
January 8, 2026
·
8 min read
1 of 73,084
Next
